• Galderma will present findings from the ARTIST post-marketing study showing that The Shayping Technique™ – a holistic treatment approach using three Restylane^® injectables – significantly enhances facial features and overall appearance, supporting its use to meet diverse patient needs¹
• Additional presentations will highlight the versat

New augmented reality solution provides digital facial assessment and potential results of injectable products from Galderma's aesthetic portfolio, as well as technology for consistent interactive "before and after" images

DALLAS, March 22, 2023 /PRNewswire/ -- Galderma announced today the launch of FACE by Galderma™, an innovative aesthetic visualization to

• Galderma will present new data from across its portfolio, including findings from the RELAX and EXPRESSION studies on Relfydess® (RelabotulinumtoxinA) highlighting its rapid onset of action as early as day one and sustained high patient satisfaction beyond six months1,2  

• Alluzience® (abobotulinumtoxinA, ABO) improves glabellar (frown) lines with high patient satisfaction
• Positive new data on the efficacy and safety of the new formulation of Sculptra® (poly-L-lactic acid, PLLA)
• Strong data from two studies showing the efficacy and safety of Galderma’s hyaluronic acid fillers

• Data for SCULPTRA^® to support new administration method licensed in Europe that is fast and convenient
• ALLUZIENCE^® data to reaffirm effectiveness and safety of first ready-to-use liquid formulation licensed in Europe  
• Galderma to host sponsored symposium to discuss initial assessment of different patient profiles, wit